You Can Now Bet on Clinical Trials Like Playoff Games, But Health Execs Say It Crosses a Line

Prediction market Kalshi launched betting markets tied to clinical trial results and FDA approvals, but healthcare leaders warn the model could enable insider trading and compromise research integrity. The development raises ethical and regulatory questions about financial incentives in clinical research.